Jon E. Grant to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Jon E. Grant has written about Dose-Response Relationship, Drug.
Connection Strength
0.803
-
Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study. J Clin Psychopharmacol. 2019 Mar/Apr; 39(2):129-134.
Score: 0.126
-
N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 May 01; 73(5):490-6.
Score: 0.104
-
Open-label pilot study of memantine in the treatment of compulsive buying. Ann Clin Psychiatry. 2012 May; 24(2):119-26.
Score: 0.079
-
Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study. Psychopharmacology (Berl). 2011 Dec; 218(3):493-502.
Score: 0.074
-
Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
Score: 0.071
-
A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010 Aug; 30(4):396-403.
Score: 0.070
-
Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
Score: 0.060
-
N-acetyl cysteine in the treatment of grooming disorders. J Clin Psychopharmacol. 2007 Apr; 27(2):227-9.
Score: 0.055
-
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
Score: 0.051
-
An open naltrexone treatment study in pathological gambling disorder. Int Clin Psychopharmacol. 2001 Sep; 16(5):285-9.
Score: 0.038
-
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 08; 33(8):1272-1280.
Score: 0.031
-
Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
Score: 0.023
-
Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol. 2006 Mar-Apr; 29(2):77-9.
Score: 0.013
-
Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
Score: 0.010